Announcements
Home ⟩ Insights
Insights
events
5 min read • April 21, 2026
Cannabis Isn’t Broken. The Market Is Reading It Wrong
3 min read • March 9, 2026
Seth Yakatan Says IgniteIt Is Where Real Cannabis Business Happens
5 min read • February 24, 2026
New Jersey Growers Say Genetics, Terpenes and Craft Cultivation Will Define the Next Phase of the Market
4 min read • February 23, 2026
New Jersey Regulators Outline the Next Phase of a Fair and Stable Cannabis Market
5 min read • February 20, 2026
Exclusive – Whoopi Goldberg: ‘I’m 70. I Like Pleasure.’ The Cannabis Conversation on Aging
3 min read • December 18, 2025
Trump Makes History with Executive Order To Reschedule Cannabis
3 min read • December 18, 2025
Investors Are Pricing the Headline. The Paperwork Is the Policy.
9 min read • December 18, 2025
The White House’s Smartest Move Isn’t Schedule III. It’s the Framing
3 min read • December 18, 2025
Hemp Is Watching Closely. Why Schedule III Could Reignite the Farm Bill Fight.
4 min read • December 17, 2025
Cannabis Rescheduling: What We Know, What’s Rumor, And What To Watch Next
3 min read • December 17, 2025
Cannabis Industry Optimism Grows As Trump Signals Marijuana Rescheduling, Here’s When Marijuana Could Move To Schedule III
Latest Headlines
View All
4 min read • April 28, 2026
Psychedelics Enter Public Markets, Optimi CEO Points to Supply Bottleneck
3 min read • April 28, 2026
This Cannabis Giant Plans Nevada Registration, Here’s What Shareholders And Investors Need To Know
2 min read • April 28, 2026
TerrAscend Extends Cash Flow Streak To 15 Quarters As Growth Returns, Shares Pop
4 min read • April 27, 2026
DEA Opens Medical Marijuana Dispensary Registration Portal April 29: What Operators Need To Know
4 min read • April 27, 2026
Federal Cannabis Policy Just Changed Forever, Here’s What Rescheduling Order Really Means And What To Expect
4 min read • April 27, 2026
EXCLUSIVE: Safe Harbor Launches First Cannabis‑Ready 401K Plan
min read • April 27, 2026
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
min read • April 27, 2026
Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema
min read • April 27, 2026
Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities
min read • April 27, 2026
Astec Announces Quarterly Dividend
min read • April 27, 2026
Près de 3 Canadiens sur 10 n’ont pas encore produit leur déclaration de revenus, alors que la date limite approche à grands pas; plus d’un sur 10 affirme qu’il manquera l’échéance, révèle une nouvelle étude de H&R Block
min read • April 27, 2026
Yukon Metals Options Copper-Gold Project from Renowned Yukon Prospector Ryan Burke, Solidifying Position in Emergent Birch District
Browse By Channels
After-Hours Center
Analyst Color
Analyst Ratings
Asia
Asset Sales
Be Your Own Boss
Binary Options
Biotech
Bonds
Broad U.S. Equity ETFs
Buybacks
Cannabis
CNBC
Commodities
Contracts
Crowdsourcing
Cryptocurrency
Currency ETFs
Dividends
Downgrades
Earnings
Earnings Beats
Earnings Misses
Econ #s
Economics
Education
Emerging Market ETFs
Emerging Markets
Entertainment
Entrepreneurship
Equities
ESG
ETFs
Eurozone
Events
Exclusives
Fast Money
FDA
Federal Reserve
Financial Advisors
Financing
Fintech
Forex
Futures
Gaming
General
Global
Government
Guidance
Health Care
Hedge Funds
Hot
Initiation
Insider Trades
Insurance
Interview
Intraday Update
IPOs
Large Cap
Latin America
Legal
Long Ideas
M&A
Macro Economic Events
Macro Notification
Management
marijuana
Market Summary
Market-Moving Exclusives
Markets
Media
Mid Cap
Movers
Movers & Shakers
New ETFs
News
Offerings
Opinion
Options
Penny Stocks
Personal Finance
Politics
Pre-Market Outlook
Press Releases
Previews
Price Target
Psychedelics
Psychology
Real Estate
Regulations
REIT
Reiteration
Restaurants
Retail Sales
Reviews
Rumors
SEC
Sector ETFs
Short Ideas
Short Sellers
Signals
Small Business
Small Cap
Small Cap Analysis
Social Media
Specialty ETFs
Sports
Sports Betting
Startups
Stock Split
Success Stories
Taxes
Tech
Technicals
Top Stories
Topics
Trading Ideas
Travel
Upgrades
WIIM
Join the Cannabis Revolution
Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.